Skip to main content
Guhan Pharmaceutical Group Co., Ltd. logo

Guhan Pharmaceutical Group Co., Ltd. — Investor Relations & Filings

Ticker · 000590 ISIN · CNE000000701 Shenzhen Stock Exchange Manufacturing
Filings indexed 1,714 across all filing types
Latest filing 2020-04-08 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 000590

About Guhan Pharmaceutical Group Co., Ltd.

https://www.tuspharma.cn

Guhan Pharmaceutical Group Co., Ltd. specializes in the research, development, production, and sale of traditional Chinese medicine (TCM) and health-related products. The company is widely recognized for its flagship product, Guhan Yangsheng Jing, which is formulated based on ancient health preservation prescriptions discovered in the Mawangdui Han Dynasty Tombs. Its product portfolio includes oral liquids, tablets, and capsules designed to enhance vitality, support kidney function, and promote overall longevity. The organization integrates classical medical theories with modern pharmaceutical manufacturing processes to ensure product efficacy and safety. Beyond its core TCM offerings, the group engages in the production of chemical drugs and health supplements, targeting markets seeking natural wellness solutions. The company emphasizes the preservation of cultural heritage through the modernization of ancient medical wisdom.

Recent filings

Filing Released Lang Actions
独立董事候选人声明(马运弢)
Board/Management Information Classification · 95% confidence The document is a public statement by an independent director candidate of a company, declaring compliance with various legal and regulatory requirements for serving as an independent director. It includes detailed attestations about qualifications, independence, and adherence to relevant laws and regulations. There are no financial statements, no discussion of company performance, no voting results, no meeting materials, and no mention of report publication. The content is focused on board/management information, specifically about the appointment and qualifications of a board member. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length (6552 characters) supports it being a full statement rather than a brief announcement or certification only.
2020-04-08 Chinese
董事会关于募集资金2019年度存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a special report from the board of directors regarding the storage and usage of raised funds for the fiscal year 2019. It details the amount of funds raised, their allocation, usage, management, and investment in financial products. It also includes auditor's verification and sponsor's opinions on the compliance and proper use of the funds. The document is comprehensive, contains detailed financial data about the fundraising and usage, and is not merely an announcement or a certification. It is a specialized report focused on the usage of capital raised by the company, which aligns with the category of Capital/Financing Update (CAP).
2020-04-08 Chinese
内部控制审计报告
Audit Report / Information Classification · 95% confidence The document is titled '内部控制审计报告' which translates to 'Internal Control Audit Report'. It references auditing standards and responsibilities related to internal control over financial reporting as of December 31, 2019. The document contains an auditor's opinion on the effectiveness of internal controls, signed by certified public accountants. It does not contain full financial statements or comprehensive annual or interim financial data, but rather focuses on the audit of internal controls. This matches the definition of an Audit Report / Information (AR), which includes standalone audit reports and applied accounting principles. The document length is 759 characters, which is sufficient for an audit report but too short for a full annual report. Therefore, the correct classification is AR with high confidence. FY 2019
2020-04-08 Chinese
第八届监事会第四次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the fourth meeting of the eighth Supervisory Board of the company, including approval of the 2019 Supervisory Board Work Report, the 2019 Annual Report, the 2019 Financial Final Accounts Report, profit distribution plan, internal control evaluation report, and special report on the use of raised funds. It also includes election of Supervisory Board members and other governance matters. The document contains no actual financial statements or detailed financial data but rather reports on approvals and decisions made by the Supervisory Board. The document length is 3486 characters, which is relatively short and more consistent with an announcement or meeting resolution rather than a full annual report or interim report. The content is primarily about governance and supervisory board decisions, including election of board members and approval of reports, which aligns with Board/Management Information filings. Therefore, the best classification is MANG (Board/Management Information).
2020-04-08 Chinese
关于参加独立董事培训并取得独立董事资格证书的承诺书
Regulatory Filings Classification · 95% confidence The document is a written commitment letter regarding independent director training and obtaining qualification certificates, referencing regulatory requirements from the Shenzhen Stock Exchange. It does not contain financial data, report results, or announcements of voting or management changes. It is a regulatory compliance-related filing but does not fit into categories like Board/Management Information or Proxy Solicitation. Given its nature as a formal declaration related to regulatory compliance, it best fits under Regulatory Filings (RNS). The document is short and does not present a report or announcement of a report publication.
2020-04-08 Chinese
2019年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2019 年年度报告全文" which translates to "2019 Annual Report Full Text" for 启迪古汉集团股份有限公司. It contains detailed sections typical of an annual report such as company overview, financial data, business analysis, management discussion, and governance information. The document length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. It includes financial figures, management analysis, business segments, and other comprehensive disclosures consistent with an official yearly report covering company activity and full financial performance. Therefore, this document fits the definition of an Annual Report (10-K). FY 2019
2020-04-08 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.